Type 2 diabetes remission after Roux-en-Y gastric bypass: a multicentered experience with long-term follow-up

被引:12
作者
Hage, Karl [1 ]
Ikemiya, Kayla [2 ]
Ghusn, Wissam [3 ]
Lu, Lauren [4 ]
Kennel, Kurt A. [5 ]
Mckenzie, Travis J. [1 ]
Kellogg, Todd A. [1 ]
Dayyeh, Barham K. Abu [3 ]
Higa, Kelvin D. [2 ]
Spaniolas, Konstantinos [6 ]
Ma, Pearl [2 ]
Ghanem, Omar M. [1 ,7 ]
机构
[1] Mayo Clin, Dept Surg, Rochester, MN 55905 USA
[2] UCSF Fresno, Fresno Heart & Surg Hosp, Fresno, CA USA
[3] Mayo Clin, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[4] Mayo Clin, Mayo Clin Alix Sch Med, Rochester, MN 55905 USA
[5] Mayo Clin, Div Endocrinol, Dept Med, Rochester, MN 55905 USA
[6] Stony Brook Med, Hlth Sci Ctr, Dept Surg, Div Endocrine & Metab Surg, Stony Brook, NY USA
[7] Mayo Clin, Endocrine & Metab Surg, 200 First St SW, Rochester, MN 55905 USA
关键词
Type; 2; diabetes; RYGB; Obesity; Bariatric surgery; BARIATRIC SURGERY; SLEEVE GASTRECTOMY; MELLITUS REMISSION; WEIGHT-LOSS; METAANALYSIS; PREDICTORS; OBESITY;
D O I
10.1016/j.soard.2023.09.025
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Roux-en-Y gastric bypass (RYGB) is associated with short- and mid-term type 2 diabetes (T2D) remission. Long-term outcomes and predictive parameters associated with remission following RYGB have not been well elucidated. Objective: Determining the overall long-term T2D remission rates following RYGB and identifying predictive variables associated with remission. Setting: Multicentered study including patients who underwent RYGB at 3 tertiary referral centers for bariatric surgery. Methods: We performed a retrospective cohort study between 2008-2017 to allow a minimum of 5 years of follow-up. We evaluated long-term T2D remission rates and annual T2D clinical and metabolic parameters up to 14 years after surgery. Predictors of remission were assessed using multivariate logistic regression. Patients were divided into 4 groups based on quartiles of total body weight loss percentage (%TBWL) to compare remission rates between groups. Results: A total of 815 patients were included (68.9% female, age 52.1 +/- 11.5 yr; body mass index 45.1 +/- 7.7 kg/m2) with a follow-up of 7.3 +/- 3.8 years. Remission was demonstrated in 51% of patients. Predictors of remission included pre-operative duration of diabetes, baseline HbA1C, insulin use prior to surgery, number of antidiabetic medications and %TBWL (all P , .01). Remission rates were proportionally associated with %TBWL quartile (Q1, 40.9%; Conclusions: Longer duration and higher severity of T2D were negatively associated with remission while higher %TBWL had a positive association. A significant proportion of patients in all quartiles experienced long-term remission after RYGB with a greater likelihood of remission correlated with greater weight loss. (Surg Obes Relat Dis 2023;19:1339- 1345.) (c) 2023 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1339 / 1345
页数:7
相关论文
共 50 条
  • [21] Gender Influence on Long-Term Weight Loss and Comorbidities After Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: a Prospective Study With a 5-Year Follow-up
    Federico Perrone
    Emanuela Bianciardi
    Domenico Benavoli
    Valeria Tognoni
    Cinzia Niolu
    Alberto Siracusano
    Achille L. Gaspari
    Paolo Gentileschi
    Obesity Surgery, 2016, 26 : 276 - 281
  • [22] Gender Influence on Long-Term Weight Loss and Comorbidities After Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: a Prospective Study With a 5-Year Follow-up
    Perrone, Federico
    Bianciardi, Emanuela
    Benavoli, Domenico
    Tognoni, Valeria
    Niolu, Cinzia
    Siracusano, Alberto
    Gaspari, Achille L.
    Gentileschi, Paolo
    OBESITY SURGERY, 2016, 26 (02) : 276 - 281
  • [23] Tighten Your Belt! Banded Roux-en-Y Gastric Bypass for Diabetes Remission?
    Egan, Aoife M.
    Vella, Adrian
    DIABETES CARE, 2022, 45 (07) : 1495 - 1497
  • [24] Predictors of long-term success after laparoscopic Roux-en-Y gastric bypass in African-American women
    Omotosho, Philip A.
    Rodriguez, Joel A.
    Jain-Spangler, Kunoor
    Mor, Alessandro
    Torquati, Alfonso
    SURGERY FOR OBESITY AND RELATED DISEASES, 2016, 12 (02) : 253 - 256
  • [25] Laparoscopic Roux-en-Y gastric bypass: 10-year follow-up
    Higa, Kelvin
    Ho, Tienchin
    Tercero, Francisco
    Yunus, Tahir
    Boone, Keith B.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2011, 7 (04) : 516 - 525
  • [26] Increase of the Adiponectin/Leptin Ratio in Patients with Obesity and Type 2 Diabetes after Roux-en-Y Gastric Bypass
    Unamuno, Xabier
    Izaguirre, Maitane
    Gomez-Ambrosi, Javier
    Rodriguez, Amaia
    Ramirez, Beatriz
    Becerril, Sara
    Valenti, Victor
    Moncada, Rafael
    Silva, Camilo
    Salvador, Javier
    Portincasa, Piero
    Fruehbeck, Gema
    Catalan, Victoria
    NUTRIENTS, 2019, 11 (09)
  • [27] Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass
    Park, Ji Yeon
    Kim, Yong Jin
    OBESITY SURGERY, 2016, 26 (04) : 749 - 756
  • [28] A Matched Comparative Analysis of Type-2 Diabetes Mellitus Remission Between Roux-en-Y Gastric Bypass and Sleeve Gastrectomy
    Hage, Karl
    Ma, Pearl
    Ghusn, Wissam
    Ikemiya, Kayla
    Acosta, Andres
    Vierkant, Robert A.
    Abu Dayyeh, Barham K.
    Higa, Kelvin D.
    Ghanem, Omar M.
    SURGICAL INNOVATION, 2024, 31 (02) : 148 - 156
  • [29] Preoperative Factors Predicting Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery for Obesity
    Hall, Tom C.
    Pellen, Mike G. C.
    Sedman, Peter C.
    Jain, Prashant K.
    OBESITY SURGERY, 2010, 20 (09) : 1245 - 1250
  • [30] Circulating magnesium status is associated with type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a long-term cohort study
    Haenni, Arvo
    Nilsen, Inger
    SURGERY FOR OBESITY AND RELATED DISEASES, 2021, 17 (02) : 299 - 307